Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Expiration (Long) of 2,640,845 SYBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | SYNLOGIC, INC. (SYBX) | Expiration (Long) | 2,640,845 | n/a |
| Mar 13, 2026 | Korro Bio, Inc. (KRRO) | Purchase | 207,100 | $2.30M |
| Feb 11, 2026 | SpyGlass Pharma, Inc. (SGP) | Conversion | 1,619,240 | n/a |
| Oct 6, 2025 | NeueHealth, Inc. (NEUE) | Exercise/Conversion | 189,195 | $1.9K |
| May 15, 2025 | NeueHealth, Inc. (NEUE) | Exercise/Conversion | 10,500 | n/a |
| Mar 13, 2025 | Senti Biosciences, Inc. (SNTI) | Conversion | 3,333,000 | n/a |
| Dec 23, 2024 | Marker Therapeutics, Inc. (MRKR) | Purchase | 554,250 | $1.77M |
| Oct 3, 2024 | NeueHealth, Inc. (NEUE) | Grant/Award | 61,865 | n/a |
| Sep 18, 2024 | MBX Biosciences, Inc. (MBX) | Conversion | 1,023,103 | n/a |
| May 14, 2024 | NeueHealth, Inc. (NEUE) | Exercise/Conversion | 4,755 | n/a |